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Summary
We provide evidence that sensory neurons regulate
the effector functions and phenotype of CD8+ T cells
during active immunosurveillance of HSV-1 latency.
Low-level viral gene expression in latently infected
sensory ganglia gives rise to a unique, functionally ac-
tive CD8+ T cell population. Surprisingly, distinct neu-
ronal subsets require different CD8 effector mecha-
nisms to maintain viral latency, with some requiring
IFN-g and others requiring lytic granules (LG). This
nonredundant efficacy of CD8+ T cell effector mecha-
nisms in maintaining viral latency is explained as fol-
lows: (1) a subset of neurons that expresses IFN-g re-
ceptors (IFN-gR+) and Qa1 responds to IFN-g, but Qa1
engagement of CD94/NKG2a blocks LG exocytosis by
CD8+ T cells; (2) another neuronal subset is responsive
toLGbecause it lacksQa1 and is refractory to IFN-gbe-
cause it also lacks IFN-gR. In the latter subset, LG ap-
pear to provide a nonlethal block of viral reactivation.
Introduction
The frequent acquisition of herpes simplex virus type 1
(HSV-1) infections early in life, and the conceptual prob-
lems associated with sterilizing immunity within latently
infectedneurons, mitigate the feasibility ofapreventative
vaccine or one designed to eradicate the virus. There-
fore, understanding the factors governing HSV-1 latency
and reactivation is a necessary prerequisite to develop-
ing therapeutic interventions designed to reduce the sig-
nificant morbidity and costs associated with recurrent
herpetic disease. During primary infections at peripheral
sites, HSV-1 gains access to nerve termini and is trans-
ported to neuronal nuclei of the sensory ganglia, and
there establishes a latent infection. HSV-1 latency has
been extensively studied in mouse trigeminal ganglia
(TG), where a lack of spontaneous reactivation suggests
a model in which factors responsible for maintaining the
virus in a latent state are optimized.
Difficulty in detecting HSV-1 lytic gene expression in
latently infected mouse sensory ganglia has led many in-
vestigators to conclude that HSV latency is character-
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trized by a viral genome that is transcriptionally silent ex-
cept for a family of latency-associated transcripts
(LATs), which do not appear to encode proteins. How-
ever, recent studies suggest the presence of a limited
array of viral lytic gene transcripts and proteins in the ab-
sence of infectious virions within neurons of latently
infected TG both in vivo and in vitro (Feldman et al.,
2002; Chen et al., 2002; Kramer and Coen, 1995; Liu
et al., 2000). The presence of viral proteins could render
latently infected neurons visible to the host immune sys-
tem, permitting immunosurveillance of HSV-1 latency.
Recent findings support a role for CD8+ T cells in main-
taining the latency of herpes viruses (Khanna et al., 2003;
Tibbetts et al., 2002; Loh et al., 2004). Indications of T cell
involvement in maintaining HSV-1 latency include the
persistent detection in latently infected mouse TG of cy-
tokines and T lymphocytes (reviewed in Khanna et al.,
2004) with CD8+ T cells in direct apposition to, and form-
ing an apparent immunologic synapse with, neurons
(Khanna et al., 2003). In the latter study conducted in
C57BL/6 mice, virtually all of the HSV-1-specific CD8+ T
cells in the latently infected TG were specific for a single
epitope on viral glycoprotein B (gB498-505), a leaky, late
lytic phase gene that is expressed at low levels before vi-
ral DNA replication, and optimally after DNA synthesis is
initiated. A small subpopulation of the HSV-1-specific
CD8+ T cells present in the TG following initial infection
recognized a subdominant epitope on viral ribonucleo-
tide reductase 1 (RR1822-829). The frequency of these
cells diminished to often undetectable levels during the
course of latency, which might suggest a lack of expres-
sion of RR1 during latency, though the low initial fre-
quency of RR1822-829-specific CD8
+ T cells renders
such an interpretation questionable.
The persistent activation of HSV-1-specific CD8+ T
cells within latently infected TG suggested that an inter-
action of these cells with latently infected neurons might
be required to maintain HSV-1 latency, as demonstrated
in ex vivo TG cultures (Liu et al., 2000; Khanna et al.,
2003). The recent observation that CD8+ T cells selec-
tively surround HSV-1 latently infected neurons in hu-
man sensory ganglia extends the murine findings to hu-
mans (Theil et al., 2003).
CD8+ T cells typically employ IFN-g production and
lytic granule (LG) exocytosis as integral mechanisms to
control viral infections (Edwards et al., 1999). The main
components of LG are perforin, a pore-forming molecule
that permits other LG components passage through cel-
lular membranes, and granzymes A and B, which func-
tion at least in part to activate the caspase system in tar-
get cells leading to apoptosis (Browne et al., 1999). The
persistence of intracellular pathogens within the nervous
system could promote immune-mediated destruction of
postmitotic neurons. Here, we demonstrate that CD8+ T
cells differentially use IFN-g and LG to maintain HSV-1
latency in individual neurons, without overt signs of im-
munopathology.
The generation and maintenance of CD8+ T cell mem-
ory has traditionally been described in models where
rapid clearance of the pathogen results in brief antigenic
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516exposure. The memory CD8+ T cells following acute in-
fection express a resting phenotype and represent an
‘‘armed and waiting’’ line of defense against future chal-
lenge (Kaech et al., 2003). In contrast, persistent models
of infection have revealed a memory phenotype charac-
terized by functional impairment resulting from pro-
longed exposure to high levels of antigen (van der
Most et al., 2003; Zhang et al., 2003). Less is known
about T cell memory that is maintained during latent viral
infections. Here we demonstrate that basal and/or inter-
mittent exposure to viral antigens in latently infected TG
results in an HSV-1-specific CD8+ T cell pool that ex-
presses a unique activation phenotype, while avoiding
exhaustion or functional impairment.
Results
Memory CD8+ T Cells in the Latently Infected TG
Express a Unique Phenotype
TG were excised from latently infected mice at 14, 34, and
120 days postinfection (dpi) and dispersed into single-
cell suspensions, and CD8+ T cells were analyzed for the
LG components granzyme B and perforin and for the ac-
tivation marker CD69 by flow cytometric analysis. More
than 95% of CD8+ T cells in the TG expressed perforin,
and >75% expressed CD69 at all times tested (Figure 1).
Granzyme B was expressed directly ex vivo by 65%,
36%, and 40% of gB-CD8+ T cells in 14, 34, and 120 dpi
TG, respectively (Figure 1). In contrast to CD69, gran-
zyme B expression in the TG was almost entirely limited
to gB-CD8+ T cells. By comparison, the resting gB-CD8+
T cells in the lungs (which do not harbor latent HSV-1)
failed to express either CD69 or granzyme B. These find-
ings are consistent with the notion that maintenance of
granzyme B, but not CD69 expression, requires persis-
tent antigenic stimulation within the latently infected TG.
Half of the gB-CD8+ T cells that survived the contrac-
tion phase of the immune response (>30 dpi) expressed
the memory/memory precursor marker CD127 (IL-7Ra;
Figure 1F). Granzyme B was similarly expressed in
CD127+ and CD1272 gB-CD8+ T cells within the TG (data
not shown). While expressing an activation phenotype
(CD69+, granzyme B+, CD62L2), the ability to survive
the contraction phase, expression of CD127, Ly6C,
CD11ahigh (Figure 1F), and production of IFN-g and TNF-
a, but not IL-2, directly ex vivo (see Figure S1 in the Sup-
plemental Data available with this article online) together
suggest a combined effector/memory phenotype.
CD8+ T Cells Use Both LG and IFN-g to Inhibit HSV-1
Reactivation from Latency in Sensory Neurons
CD8+ T cells can uniformly block HSV-1 reactivation in
latently infected TG cultures, whereas recombinant
IFN-g is only partially protective (Liu et al., 2001; Decman
et al., 2005). Since a significant portion of gB-CD8+ T
cells in latently infected TG expressed perforin and gran-
zyme B directly ex vivo, we investigated whether LG are
capable of preventing HSV-1 reactivation in neurons that
are refractory to IFN-g. TG were excised shortly after the
establishment of HSV-1 latency (14 dpi), and late in la-
tency (34 dpi), they were dispersed into single-cell sus-
pensions and depleted of endogenous CD8+ T cells. We
routinely observe 4–6 reactivation-competent neurons
in CD8+ T cell-depleted TG cultures. Therefore, to sepa-
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rrate the reactivation-competent neurons into different
wells, cultures were prepared with 1/10 TG equivalent
of cells/well of a 96-well tissue culture plate and were
monitored for HSV-1 reactivation from latency. Cultures
received either no CD8+ T cells or 1 3 104 gB-CD8+ T
cells that were previously isolated and expanded from
HSV-1-infected TG of either wild-type (wt) or perforin
knockout (PfP) C57BL/6 mice and were incubated with
anti-IFN-g or control antibody. Preliminary characteriza-
tion of the wt and PfP CD8+ T cells revealed comparable
expression of granzyme B (>70%), comparable produc-
tion of IFN-g and LG release following stimulation with
gB-pulsed targets (>95%), and perforin expression at
99%–100% of wt and 0% of PfP (data not shown).
The results obtained with 14 dpi and 34 dpi TG were
essentially identical (Figures 2A and 2B), showing reac-
tivation in 60% of cultures that did not receive CD8+ T
cells and no reactivation in cultures that received wt
CD8+ T cells. The PfP CD8+ T cells, which produce copi-
ous amounts of IFN-g, were significantly less efficient (p
< 0.02) than wt CD8+ T cells in blocking HSV-1 reactiva-
tion (Figure 2). The reactivation frequency was ~36% in
cultures receiving PfP CD8+ T cells alone and 60% (no
protection) in cultures that received PfP CD8+ T cells
plus anti-IFN-g. Thus, some neurons are refractory to
IFN-g and require LG to prevent reactivation.
Whereas wt CD8+ T cells alone afforded complete
protection, reactivation was observed in ~36% of cul-
tures that received wt CD8+ T cells plus anti-IFN-g (p <
0.02), and this frequency was not altered by adding up
to 5-fold more CD8+ T cells to the cultures (see Figure
S2). Since similar numbers of CD8+ T cells were recov-
ered from all cultures (data not shown), the reduced pro-
tection in cultures that received PfP CD8+ T cells or wt
CD8+ T cells plus anti-IFN-g was not related to reduced
expansion or survival of CD8+ T cells in culture. These
data demonstrate that some neurons can be protected
by IFN-g, but not by LG, whereas other neurons can
be protected by LG but not by IFN-g.
LG Exocytosis by CD8+ T Cells Is Regulated during
Interactions with Latently Infected Neurons
TG were excised 14 or 34 dpi, and endogenous CD8+ T
cells were stimulated for 6 hr with gB peptide pulsed or
HSV-1-infected stimulator cells and assayed for LG exo-
cytosis (surface CD107a) and intracellular IFN-g. When
optimally stimulated, approximately 50% of CD8+ T cells
from the TG expressed both activities, and virtually no
differential expression was observed (Figure 3A). Fur-
thermore, the identical response to HSV-1-infected and
gB peptide-pulsed targets demonstrates that all HSV-
1-reactive cells in the TG are specific for the gB epitope.
To determine whether CD8+ T cells use the same effec-
tor mechanisms in responding to latently infected neu-
rons, latently infected TG were cultured for various peri-
ods, and the capacity of latently infected neurons to
induce IFN-g production and LG exocytosis by endo-
genous CD8+ T cells was tested. Because latency was
established in the TG with a recombinant virus that ex-
presses EGFP from the viral ICP0 (immediate early) pro-
moter, we were able to visually verify that viral gene
expression was limited to neurons during the 78 hr obser-
vation period as previously noted (Decman et al., 2005).
CD8+ T cells showed a marked predilection for IFN-g
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517Figure 1. Virus-Specific CD8+ T Cells in the TG Express a Unique Effector/Memory Phenotype Indicative of Persistent TCR Stimulation
Single-cell suspensions of TG and lungs from individual mice at 14 days postinfection (dpi) and 34 dpi were stained directly ex vivo for CD8,
CD45, gB Dimer, CD69, CD127, CD11a, Ly6C, CD62L, perforin, and granzyme B.
(A) Dot plots in which cells (TG) were gated on CD8 and analyzed for gB498-505 specificity and granzyme B, or gB498-505 specificity and CD69.
(B) Dot plots in which cells (TG) were gated on CD8 and analyzed for perforin with perforin knockout CD8+ T cells used as a control.
(C) Scatter plots showing granzyme B expression by gB498-505-specific and nonspecific CD8
+ T cells in TG.
(D) Scatter plots showing CD69 expression by gB498-505-specific and nonspecific CD8
+ T cells in TG.
(E) Scatter plots comparing granzyme B expression and CD69 expression by gB498-505-specific CD8
+ T cells in TG and lungs at 34 dpi.
(F) Bar graphs (n = 5) showing expression of CD127, CD11a, Ly6C, and CD62L by gB498-505-specific CD8
+ T cells in TG at 34 dpi. Error bars denote
the standard error of the mean.
Re
tra
cte
dproduction over lytic granule exocytosis when respond-
ing to latently infected neurons (Figures 3B and 3C).
We demonstrated that a low epitope density could not
explain the preferential production of IFN-g by CD8+ Tcells responding to latently infected neurons because
LG exocytosis occurred at a 2 logs lower epitope density
than that required to induce IFN-g production (see
Figure S3).
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Release by CD8 T Cells in Response to
Latently Infected Neurons
Binding of Qa1 to the inhibitory receptor CD94/NKG2A
selectively inhibits LG exocytosis by CD8+ T cells and
NK cells in some systems (Miller et al., 2002; Kubota
et al., 1999). The possibility that NKG2A signaling regu-
lated LG exocytosis by CD8+ T cells in response to la-
tently infected neurons was supported by the fact that
the majority (75%–85%) of gB-CD8+ T cells in latently in-
fected TG expressed the heterodimer CD94/NKG2A
(Figure 4). CD94/NKG2A expression like granzyme B ex-
pression was restricted largely to the gB-CD8+ T cells
(Figure 4B). Notably, resting gB-CD8+ T cells in the lungs
did not express CD94/NKG2a, whereas those in the
spleen did.
The addition of anti-Qa1 mAb to TG cultures com-
pletely abrogated the inhibition of lytic granule exocyto-
sis during interaction of CD8+ T cells with latently in-
fected neurons (Figure 5A). Moreover, blocking Qa1/
NKG2A interaction restored the ability of gB-CD8+ T
cells to inhibit HSV-1 reactivation in all neurons in the
presence of IFN-g neutralizing antibody (Figure 5B). In
Figure 2. CD8+ T Cells Use Either a Perforin-Dependent or an IFN-g-
Dependent Mechanism to Maintain HSV-1 Latency in Individual TG
Neurons
TG were obtained at 14 dpi (A) or 34 dpi (B). Pooled TG suspensions
from 20 mice were depleted of endogenous CD8+ T cells and sus-
pended at 1 TG equivalent of cells/ml, and 0.1 ml of cells (0.1 TG
equivalent) were dispensed into each well of a 96-well plate. Each
well received 0.1 ml of medium only (no CD8+ T cells), 1 3 104
gB498-505-specific CD8
+ T cells previously expanded from TG of
wild-type mice plus control antibody (wt CD8) or anti-IFN-g antibody
(wt CD8 + anti-IFNg), or 1 3 104 gB498-505-specific CD8
+ T cells pre-
viously expanded from TG of perforin knockout mice plus control
antibody (PfP CD8) or anti- IFN-g antibody (PfP CD8 + anti-IFNg).
n = 48/group. HSV-1 reactivation was monitored by sampling culture
supernatants and performing plaque assays. The experiment was
repeated twice with similar results. Both Pfp CD8 and wt CD8 +
a-IFNg were significantly less efficient than wt CD8 in preventing
HSV-1 reactivation (p < 0.02, Kaplan-Meier survival curve analysis).
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trthese experiments, TG cultures were depleted of all
CD45+ (bone marrow-derived) cells prior to reconsti-
tution with gB-CD8+ T cells. These CD45-depleted TG
cultures lacked APCs, providing further assurance of
a direct interaction between CD8+ T cells and latently
infected neurons. As expected, anti-Qa1 antibody had
no effect on the capacity of PfP CD8+ T cells to inhibit
HSV-1 reactivation.
Do LG prevent HSV-1 reactivation by killing neurons?
The small number of reactivation-competent neurons
that require CD8+ T cell protection necessitated the
use of an indirect assessment of cytotoxicity that is
based on the assumption that only neurons that survive
protection will be able to reactivate the virus when CD8+
T cell function is subsequently compromised. Accord-
ingly, TG were excised 34 dpi and depleted of CD45+
cells, and cultures were monitored for HSV-1 reactiva-
tion after the addition of wt gB-CD8+ T cells. Cultures
that received wt gB-CD8+ T cells plus anti-IFN-g mAb
(LG protection only) exhibited reactivation frequencies
that were approximately 50% those of unprotected cul-
tures with no CD8+ T cells (Figure 5C). However, the ad-
dition of anti-CD8 mAb to these cultures 8 days after cul-
ture initiation (when reactivation was maximal in
unprotected cultures) elevated their reactivation fre-
quency to that of unprotected cultures. Thus, neurons
that are protected from reactivation by LG remain viable
and capable of supporting HSV-1 reactivation.
TG cultures that received wt gB-CD8+ T cells plus anti-
IFN-g and anti-Qa1 mAb showed 0% reactivation (Fig-
ure 5C). These cultures contained neurons in which re-
activation is normally blocked by LG and survive this
protection (see above), and those in which HSV-1 reac-
tivation is normally blocked by IFN-g, but are now forc-
ibly protected by LG due to the presence of anti-IFN-g
and anti-Qa1. However, the addition of anti-CD8 mAb
to these cultures 8 days after culture initiation only in-
creased the reactivation frequency to 50% that of un-
protected cultures, indicating that only half of the neu-
rons remained viable and/or reactivation competent
following an LG block of reactivation. Thus, it appears
that neurons that are normally protected by IFN-g are
susceptible to the lethal effects of LG. However, the al-
ternative possibility that LG push these neurons into
a stable latency that does not require continued CD8+
T cell presence cannot be ruled out.
Distinct Phenotypes of Latently Infected Neurons
Define the Requirements for IFN-g or LG in
Blocking HSV-1 Reactivation
Consistent with the unique activation phenotype of gB-
CD8+ T cells in latently infected TG is the observation of
multiple neurons expressing the HSV-1 gB promoter
within all latently infected TG examined (Figure 6A).
These findings suggest that at any given time in a latently
infected ganglion, a small number of neurons express
the antigen that is recognized by HSV-1-specific CD8+
T cells.
Since neurons exhibit differential susceptibility to IFN-
g- or LG-mediated protection, and LG protection is reg-
ulated by Qa1, we determined whether latently infected
TG neurons differentially express IFN-gR and Qa1.
Whole mounts of TG that were latently infected with a
virus that expressed EGFP from a gB promoter were
d
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for IFNg Production when Interacting with
HSV-1 Latently Infected Neurons
(A) Single-cell suspensions of pooled TG from
mice at 14 or 34 dpi were stimulated directly
ex vivo for 6 hr with histocompatible fibro-
blasts transfected with gB and pulsed with
gB498-505 peptide or infected with HSV-1,
and CD8+ T cells were analyzed for lytic gran-
ule release (CD107a) and IFN-g production.
Representative dot plots are shown.
(B and C) Single-cell suspensions of pooled
TG from mice at 14 days after infection with
RE-pICP0-EGFP HSV-1 were cultured (1/10
TG cultures) for various periods, and endoge-
nous CD8+ T cells were assayed for lytic gran-
ule release (CD107a) and IFN-g production.
Representative dot plots (B) are shown from
cells assayed 48–54 hr after culture initiation,
and bar graphs representing three experi-
ments (C) are shown illustrating the percent-
age of CD107a expression and IFN-g produc-
tion for each of the culture periods (*p <
0.001). Error bars denote the standard error
of the mean. EGFP was restricted to neurons
during the assay, indicating a lack of reactiva-
tion from latency.ct
simultaneously stained for IFN-gR and Qa1. As illus-
trated in Figure 6, IFN-gR and Qa1 were coexpressed
on about half of the EGFP-positive neurons, but were
low to undetectable on the remainder. This pattern was
uniformly observed on both gB promoter-positive and -
negative neurons. Collectively, our findings strongly
suggest that two phenotypically distinct subpopulations
of latently infected neurons require CD8+ T cell protec-
tion (illustrated in Figure 7). In IFN-gR+, Qa1+ neurons,
HSV-1 reactivation is inhibited by IFN-g and LG exocyto-
sis is blocked, whereas in IFN-gR2, Qa12 neurons, HSV-1
reactivation is inhibited by LG.
Discussion
It is becoming increasingly evident that CD8+ T cells in
HSV-1 latently infected ganglia receive persistent or in-
termittent TCR stimulation through detection of viral
epitopes on latently infected neurons. Studies incorpo-
rating immunohistochemistry and in situ hybridization
demonstrated that HSV-1 late gene expression occurs
as a rare event (1–2 neurons per 10 latently infected gan-
glia) in infected mouse ganglia that lack detectable infec-
tious virus (Feldman et al., 2002). Using a recombinant
HSV-1 that expresses EGFP from the viral gB promoter,
we demonstrate that late gene expression is a much
more common event, occurring in 2–4 neurons of every
latently infected TG tested. This is consistent with our
previous demonstration that gB-CD8+ T cells surround
R
ramultiple neurons in each latently infected TG and forman apparent immunologic synapse (Khanna et al., 2003).Uncertainties remain regarding the phenotypic andfunctional characteristics that define CD8+ memory Tcells. Using an acute LCMV infection model, Ahmed
and colleagues showed that CD127 is expressed on
a small population of memory precursor CD8+ T cells
during the expansion phase and on approximately
90% of virus-specific CD8+ T cells during the memory
phase (Kaech et al., 2003). The CD8+ memory precursors
express a variety of effector molecules including gran-
zyme B but gradually lose granzyme B expression as
they differentiate into full memory cells. To our knowl-
edge, CD127 is the most reliable marker for identifying
memory CD8+ T cells and their precursors.
The persistence of antigen clearly influences the de-
velopment of CD8+ T cell memory. Acute infections give
rise to at least two phenotypically and functionally dis-
tinct populations of memory CD8+ T cells. Central mem-
ory cells (CD8+ TCM) are CD127
+, CD62L+, CCR7+, reside
mainly in lymphoid tissues, and produce IL-2, but little if
any IFN-g or TNF-a when stimulated directly ex vivo.
Effector memory cells (CD8+ Tem) are CD127
+, CD62L2,
CCR72, reside mainly in nonlymphoid tissue, and pro-
duce IFN-g and TNF-a, but little if any IL-2 when stimu-
lated directly ex vivo. Neither CD8+ TCM nor CD8
+ TEM
express granzyme B directly ex vivo (Wherry et al.,
2003b).
Recent reports demonstrate that chronic infections
give rise to a CD8+ T cell population that is CD127lo,
Immunity
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rdoes not proliferate in response to IL-7 or IL-15, can only
persist in the presence of antigen, and produces low lev-
els of IFN-g, TNF-a, and IL-2 when stimulated with anti-
gen in vitro (Wherry et al., 2003a, 2004; Lang et al., 2005).
Following primary HSV-1 corneal infection, gB-CD8+ T
cells in the TG and lungs undergo expansion and con-
traction and then establish a homeostatic population
(Khanna et al., 2003; our unpublished observation). Per-
sistent low-level antigenic stimulation of the gB-CD8+ T
cells within the latently infected TG gives rise to a popu-
lation of CD8+ T cells that express the phenotype
(CD127+/2, CD69+, Ly6C+, CD11ahi, CD62L2 granzyme
B+/2, and CD94/NKG2a+). This contrasts with the resting
phenotype (CD692, granzyme B2, CD94/NKG2a2) of
gB-CD8+ T cells in the noninfected lungs of the same
mice.
The effector functions of gB-CD8+ T cells in latently in-
fected TG (granzyme B+, IFN-g+, TNF-a+, IL-22) are sug-
gestive of effector cells that survived contraction. How-
ever, expression of CD127 in conjunction with effector
functions is more consistent with persistence of a CD8
memory precursor population. Phenotypically, these
cells also resemble the CD8+ T cells generated during
chronic infections, but they do not exhibit the functional
impairment that results from chronic high-level anti-
genic exposure. Thus, the persistent low-level antigenic
Figure 4. gB498-505-Specific CD8
+ T Cells Express the Inhibitory Re-
ceptor Complex CD94/NKG2A during HSV-1 Latency
Single-cell suspensions of TG at 14 days postinfection (dpi) and TG,
lungs, and spleens at 34 dpi from individual mice were stained di-
rectly ex vivo for CD8, CD45, gB Dimer, CD94, and NKG2A/C/E.
(A) Representative dot plots in which cells from TG, lungs, and
spleen were gated on gB498-505-specific CD8
+ T cells and analyzed
for CD94 and NKG2 A/C/E expression.
(B) Scatter plots comparing CD94/NKG2 A/C/E coexpression by
gB498-505-specific and nonspecific CD8
+ T cells in TG at 14 and 34
dpi and by gB498-505-specific CD8
+ T cells in the lungs and spleen
at 34 dpi.
R
texposure of CD8+ T cells within HSV-1 latently infected
tissue gives rise to a unique population of cells with
combined memory and effector characteristics.
Previous studies incorporating explanted TG dem-
onstrated that CD8+ T cells block HSV-1 reactivation
without destroying the pool of reactivation-competent
neurons (Liu et al., 2000) but did not define the mecha-
nisms CD8+ T cells used to inhibit reactivation. Surpris-
ingly only 2–6 neurons in each latently infected mouse
TG appear to be reactivation competent in ex vivo TG cul-
tures that lack CD8+ T cell protection. However, a similar
number of neurons reactivate in vivo in the TG of stressed
mice (Sawtell and Thompson, 2004) and express the gB
promoter in latently infected TG (Figure 6), supporting
the relevance of the ex vivo reactivation model.
By distributing the cells from each TG into 10 wells, we
were able to separate the reactivation-competent neu-
rons into different wells and demonstrate that gB-
CD8+ T cells can block reactivation in all neurons and
that approximately half of the reactivation-competent
neurons require IFN-g to maintain latency. We were in-
trigued by the fact that these neurons could not be pro-
tected by LG exocytosis. This raised the interesting pos-
sibility that neurons that are protected by IFN-g are
capable of actively inhibiting LG exocytosis by CD8+ T
cells. In support of this theory, CD8+ T cells in latently in-
fected TG that can produce IFN-g and release LG when
optimally stimulated exhibited a strong predilection for
IFN-g production when stimulated by latently infected
neurons. Thus, some neurons appeared to specifically
inhibit LG exocytosis by CD8+ T cells without impairing
their ability to produce IFN-g.
How might neurons differentially inhibit LG exocytosis
by CD8+ T cells? One possibility arose from the observa-
tions that engagement of the CD94/NKG2A receptor on
CD8+ T cells by the MHC class Ib molecule Qa1 blocked
cytotoxicity but not IFN-g production by CD8+ T cells
stimulated with a polyoma virus epitope (Miller et al.,
2002). Interestingly, in the same study, NKG2A ligation
failed to block IFN-g production or cytotoxicity in re-
sponse to an LCMV epitope. The reason for this discrep-
ancy is not clear, but might reflect a different balance be-
tween positive signals (TCR, costimulation) and negative
signals (CD94/NKG2A) in the two models. In our model,
TCR signaling is likely to be low due to low MHC class I
and viral gene expression in latently infected neurons.
We observed that: (1) CD94/NKG2A is expressed on
most gB-CD8+ T cells in latently infected TG; (2) half of
TG neurons coexpress Qa1 and IFN-gR, while the other
half express neither; and (3) CD8+ T cells can block
HSV-1 reactivation from latency in half of the reactiva-
tion-competent neurons through IFN-g, but not through
LG, and in half of the reactivation-competent neurons
though LG but not through IFN-g. Together, these find-
ings suggest two subpopulations of TG neurons (illus-
trated in Figure 7). Wild-type and PfP CD8+ T cells protect
one neuronal subpopulation exclusively through IFN-g
because they express IFN-gR and inhibit LG exocytosis
through Qa1 ligation of NKG2A. The other neuronal sub-
population is refractory to IFN-g due to a lack of IFN-gR,
but can be protected by LG because they also lack Qa1.
These neurons are protected by wt, but not by perforin-
deficient CD8+ T cells. Although we demonstrate differ-
ential IFN-gR and Qa1 expression on TG neurons in
t
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T Cells in Latently Infected TG Is Regulated
by Qa1
(A) Single-cell suspensions of pooled TG ob-
tained from mice at 14 dpi were prepared and
cultured as described in Figure 3C, except
that anti-Qa1 or control mAb was added at
culture initiation. Lytic granule release (sur-
face CD107a) and IFN-g production by en-
dogenous CD8+ T cells in response to latently
infected neurons was measured during the
last 6 hr of incubation (*p < 0.001). Error
bars denote the standard error of the mean.
(B) Pooled suspensions of 20 TG obtained 34
dpi were depleted of endogenous CD45+
(bone marrow-derived) cells, and 0.1 TG
equivalent of cells was added to each well
of a 96-well plate. The cultures received no
CD8+ T cells or 1 3 104 gB498-505-specific
cells from wild-type (wt CD8) or perforin-defi-
cient (PfP CD8) CD8+ T cell lines. Cultures
with CD8+ T cells received anti-Qa1 (a-Qa1)
or both anti-IFN-g and anti-Qa1 (a-IFNg +
a-Qa1) at culture initiation. HSV-1 reactivation
was monitored by assaying serial samples
of culture supernatants for infectious virus
(n = 32 cultures/group). The experiment was
repeated twice with similar results.
(C) Pooled TG suspensions from 50 mice (34
dpi) were depleted of endogenous CD45+
cells and cultured with no CD8+ T cells or
with 1 3 104 gB498-505-specific wt or PfP CD8
+ T cells. Cultures with CD8+ T cells received anti-IFN-g mAb (a-IFNg) or both anti-IFN-g and
anti-Qa1 mAb (a-IFNg + a-Qa1) at culture initiation. 8 days later, cultures containing CD8+ T cells received either anti-CD8 (a-CD8 (d8)) or control
antibody. HSV-1 reactivation was monitored by assaying serial samples of culture supernatants for infectious virus (n = 30 cultures per group).
The experiment was repeated twice with similar results. ct
situ, the capacity of CD8+ T cells to differentially regulate
HSV-1 reactivation from latency through IFN-g and LG
could be influenced by changes that occur in neurons
following ganglionic excision and will need to be con-
firmed in vivo.
An important question is whether or not LG exocytosis
by CD8+ T cells leads to neuronal death. The low fre-
quency of reactivation-competent neurons in ex vivo
cultures renders standard cytotoxicity assays ineffec-
tive. The assay used in this study is based on the as-
sumption that if a CD8+ T cell prevents reactivation by
killing a neuron, that neuron will no longer be able to re-
activate the virus upon subsequent inhibition of CD8+ T
cell function. Wild-type gB-CD8+ T cells completely
blocked HSV-1 reactivation in TG cultures. Half of that
protection was lost by 8 days in culture when IFN-g
was neutralized, and the remaining protection was me-
diated by LG. However, when anti-CD8 mAb was added
8 days after culture initiation, the LG-protected neurons
promptly reactivated. Thus, IFN-gR2, Qa12 neurons that
are normally protected from HSV-1 reactivation by LG
appear to be resistant to LG lethality. In contrast, when
CD8+ T cells are forced to use LG exocytosis to prevent
HSV-1 reactivation in IFN-gR+, Qa1+ neurons (i.e., in the
presence of anti-IFN-g + anti-Qa1 mAb), the neurons ap-
pear to be killed by the LG, in that the virus does not re-
activate in these neurons when CD8+ T cell function is in-
hibited by anti-CD8 mAb. These findings suggest (1) that
the IFN-gR2, Qa12 neurons are less susceptible to apo-
ptosis induction by LG than their IFN-gR+, Qa1+ counter-
parts and (2) that LG prevent reactivation of HSV-1 in IFN-
gR2, Qa12 neurons through a noncytotoxic mechanism.
R
raThe reduced susceptibility of the IFN-gR2, Qa12 neu-rons to apoptosis induction by LG might reflect constitu-tive expression of antiapoptotic proteins by the neuronsand/or expression of antiapoptotic viral molecules. Forinstance, only a portion of HSV-1 latently infected neu-rons express detectable levels of LATs, which appearto inhibit apoptosis in neurons (Perng et al., 2000). A pre-
cedent for nonlytic inhibition of viral gene expression
was provided by studies showing the ability of granzyme
A to inhibit ectromelia virus replication without killing the
host cell (Mullbacher et al., 1996). Granzyme A has been
shown to restrict the interneuronal spread of HSV-1
within sensory ganglia prior to the establishment of la-
tency without obvious loss of neurons (Pereira et al.,
2000). However, it was unclear whether granzyme A ex-
erted its effect directly on infected neurons or limited vi-
rus spread by inhibiting replication in accessory cells. In
latently infected ganglia, virus is restricted to neurons.
Therefore, blocking HSV-1 reactivation from latency
and virion formation of necessity involves a direct inter-
action between the CD8+ T cells and latently infected
neurons. We propose that neurons that require LG pro-
tection from HSV-1 reactivation from latency are resis-
tant to LG-induced apoptosis and that LG block HSV-1
reactivation in these neurons by a nonlytic mechanism.
These possibilities are currently being investigated.
Understanding the mechanisms underlying the ability
of CD8+ T cells to maintain HSV-1 latency has important
implications for developing immunology-based therapy
designed to prevent recurrent herpetic disease. Interac-
tion between immune effector cells and postmitotic neu-
rons is not unique to herpes virus infections, but extends
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522Figure 6. Heterogeneous In Situ Expression of IFN-g Receptor and Qa1 by Trigeminal Ganglion Neurons during HSV-1 Latency
Confocal microscopic images of representative whole TG obtained 34 days after corneal infection with a recombinant RE HSV-1 that expresses
EGFP from the viral gB promoter (RE-pgB-EGFP) and stained for IFN-g receptor a (IFN-gRa) and Qa1. All images were acquired in grayscale and
pseudocolored to clarify areas of colocalization using Metamorph software.
(A) Single-color fluorescence of EGFP (green), IFN-gRa (red), and Qa1 (blue) and overlay show two latently infected neurons in which the gB pro-
moter is active, where one neuron coexpresses IFN-gRa and Qa1, and the other fails to express either. Yellow single-pixel width lines used for
linescan analysis.
(B) Linescan analysis showing grayscale intensity levels of EGFP, IFN-gRa, and Qa1 along each indicated yellow line (see [A]) illustrates coloc-
alization of the three markers at the cell surface. Values used for linescan analysis reflect the original acquisition intensities.
(C) Single color fluorescence of pgB-EGFP (green), IFN-gRa (red), and Qa1 (blue) and overlay show a TG neuron in which the gB promoter is not
active. The corresponding linescan analysis is shown to the right of the overlay image.
(D) Neuronal gB promoter, IFN-g receptor, and Qa1 expression were quantified in three latently infected TG.
tra
cte
dto other infectious and autoimmune diseases. As such,
harnessing protective mechanisms employed by the
nervous system may prove to be invaluable in develop-
ing therapies for neuroinflammatory diseases.
Experimental Procedures
Recombinant Virus Construction and Characterization
Two recombinant HSV-1-expressing EGFP from viral promoters
were produced for this study (RE-pICP0-EGFP and RE-pgB-
EGFP). Both viruses were created on HSV-1 RE background and
are null mutants at the gC locus. The construction and characteriza-
tion of the RE-pICP0-EGFP virus was previously described (Decman
et al., 2005). The construction of a recombinant herpes simplex vi-
rus-expressing EGFP from the gB promoter (RE-pgB-EGFP) was
R carried out in a similar fashion. The promoter of gB (containing allthe sequences from the first base pair of the translation-initiatingATG to approximately 500 bp upstream) was PCR amplified with pri-mers that contained 50 sequences to add HindIII at the distal end and
bamHI at the proximal end (proximal primer 50-gggatcccgtcgtgcccc
ccgtcaggtagc-30 and distal primer 50-gggaagctttgacgaagcggtcgttgg
cca-30). Amplified DNA cut with these enzymes was cloned directly
upstream of the EGFP gene in the plasmid pgC-EGFP, placing the
gB promoter to drive expression of the EGFP gene. Recombinant
virus was derived, purified, and characterized as just detailed.
RE-pgB-EGFP showed a characteristic g 1 gene expression pattern,
in that while EGFP expression was observed microscopically in Vero
cells 2.5 hr after infection, there was no expression in typical cyclo-
heximide reversal experiments; abundant expression detected by
immunoblot was found at 12 hr postinfection; and such expression
was inhibited in parallel cultures in the presence of 400 mg/ml PAA.
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523Figure 7. Proposed Model Explaining Differential Use of CD8+ T Cell Effector Functions in Maintaining HSV-1 Latency in Neurons
Our findings suggest that there are two types of CD8+ T cell/neuron interactions. The latently infected neuron on the left represents those that
cannot be protected by IFN-g because they lack IFN-g receptors (see Figure 6). These neurons also lack Qa1, thus permitting lytic granule exo-
cytosis. We propose that lytic granules inhibit HSV-1 reactivation from latency in these neurons by a nonlytic mechanism, since they appear to be
viable in situ (Figure 6) and are able to reactivate after CD8+ T cell protection is abrogated (Figure 5). The latently infected neuron on the right
represents those that can only be protected by IFN-g because they express IFN-g receptors (see Figure 6) and block lytic granule exocytosis
through a Qa1-dependent mechanism (see Figure 5). These neurons appear to be susceptible to the lethal effects of LG (see Figure 5).t d
HSV-1 Infection
Wild-type (6- to 8-week-old female C57BL/6(B6) (H-2b) mice and
perforin knockout (C57/BL/6-Pfptm1sdz mice) (H-2b) (Jackson Labo-
ratory)) were anesthetized by intraperitoneal (i.p.) injection of 2.0
mg ketamine hydrochloride and 0.04 mg of xylazine (Phoenix Scien-
tific; St. Joseph, MO) in 0.2 ml of HBSS (Biowhittaker; Walkersville,
MD). Wild-type (wt) or recombinant RE strain of HSV-1 was grown
in Vero cells, and intact virions were purified using Optiprep gra-
dients according to manufacturer’s instructions. (Accurate Chemi-
cal and Scientific Corporation; Westbury, NY). Corneas of anesthe-
tized mice were bilaterally scarified 10 times in a crisscross
fashion using a sterile 30-gauge needle, and the eyes were infected
topically with 3 ml of RPMI (Biowhittaker) containing 33 105 plaque-
forming units (PFU) of HSV-1. All animal experiments were con-
ducted in accordance with the Institutional Animal Care and Use
Committee of the University of Pittsburgh.
Expansion of gB498-505-Specific CD8
+ T Cell Lines from TG
CD8+ T cells were isolated from HSV-1-infected trigeminal ganglia of
wild-type (wt) mice and from perforin knockout (PfP) mice by mag-
netic activated cell sorting (MACS, Miltenyi Biotec, Auburn, CA) ac-
cording to the manufacturer’s instructions. 13 106 CD8+ T cells per
well were stimulated in 12-well plates by the addition of 2.53 105 mi-
tomycin C-treated (0.4 mg/ml, Sigma-Aldrich; St. Louis, MO) gB-
transfected cells (B6/T-350gB)/well. CD8+ T cells were maintained
in Iscoves Modified Dulbecco’s Medium (Biowhittaker) containing
10% fetal calf serum, 5 3 105 M b2-ME, 10% Rat T Cell Stim (Fisher
Scientific), and 5% Methyl a-D-Mannopyranoside (Sigma-Aldrich).
T cells were stimulated every 72 hr and alternately rested. CD8+
T cell lines routinely tested 100% gB498-505 specific by flow cyto-
metric analysis using gB498-505 complexed Phycoerythrin (PE)-
conjugated H-2Kb dimmers (BD Pharmingen, San Diego, CA).
Single-Cell Suspensions of TG
At various times after corneal infection, mice were injected with 0.3
ml of 1000 U/ml filter-sterilized heparin (Sigma-Aldrich; St. Louis,
MO) and anesthetized by i.p. injection of ketamine hydrochloride
and xylazine. Mice were euthanized by exsanguination, and both
TG were excised. The two TG of individual mice, and where indi-
cated the TG of groups of mice, were pooled and digested in 100
ml of DMEM (Biowhittaker) containing 10% FCS and 400 U/ml of col-
lagenase type I (Sigma Chemical Company) per TG for 1 hr at 37ºC.
The TG were dispersed into single-cell suspensions by trituration.
R
t aPreparation and Monitoring of TG Cultures
At 14 or 35 days after corneal infection with wt HSV-1 RE, pooled TG
cells were counted and depleted of CD8+ T cells or all CD45+ cells by
immunomagnetic separation via magnetic anti-CD8 or anti-CD45
mAb-coated beads (6 beads/cell, Dynal ASA, Oslo, Norway) as pre-
viously described (Liu et al., 2001). The efficiency of depletion was
greater than 98% as determined by flow cytometric analysis. As
some neurons and supporting cells were lost during immunomag-
netic separation, adjustments to preseparation neuron density
were made. The equivalent number of cells from 1/10 of a TG was
added to each well of a 96-well tissue culture plate and incubated
with 200 ml of DMEM (Biowhittaker) containing 10% FCS (HyClone,
Logan, UT) and 10 U/ml of recombinant murine IL-2 (R&D Systems,
Inc., Minneapolis, MN). Cultures received 1 3 104 gB498-505-specific
CD8+ T cells that were previously isolated and expanded from the
TG of wt or PfP mice. Each set of cultures received either 20 mg/ml
of a control mAb (anti-HLA-DR, clone 2.83), mAb to IFN-g (clone
R4-6A2), or a combination of mAb to IFN-g and mAb to Qa1 (20
mg/ml, clone 6A8.6F10.1A6). Additional cultures received no CD8+
T cells or antibody. In one set of experiments, all cultures that re-
ceived gB498-505-specific CD8
+ T cells from wt mice received 100
mg/ml of either CD8 mAb (clone 2.43) or control mAb (anti-HLA-
DR, clone 2.83). HSV-1 reactivation from latency was assessed as
previously described (Liu et al., 2000) based on the presence of viral
cytopathic effect, and detection of infectious virus in serial samples
of culture supernatant was performed via a plaque assay on Vero
cell monolayers.
Reagents
Peptides gB498-505 (SSIEFARL) were purchased from Research Ge-
netics (Invitrogen Corporation, Carlsbad, CA). Peptide purity was
confirmed to be >95% by reverse-phase HPLC analysis. Phycoery-
thrin (PE)-conjugated H-2Kb dimers were purchased from BD Phar-
mingen and were complexed with gB498-505 peptide overnight prior
to use. Rat anti-mouse APC-Cy7-conjugated anti-CD8a (clone 53-
6.7), fluorescein isothiocyanate-conjugated anti-NKG2 A/C/E (20d5),
CD107a (1d45), CD62L (MEL-14), Ly-6C(RB6-8c5), and anti-CD69
(H1.2F3), APC-conjugated anti-IFNg (XMG1.2), PE-Cy7-conjugated
anti-CD11a (2D7), APC-conjugated anti-IL-2 (JES6-5H4), PE-
conjugated anti-TNFa (MP6-XT22), and PERCP-conjugated anti-
CD45 (30-F11) were purchased from BD Pharmingen. It haspreviously
been shown that the NKG2A isoform of the NKG2 A/C/E family is ex-
clusively expressed in the mouse model of HSV-1 infection (Wojtasiak
Immunity
524et al., 2004). Endotoxin-free mouse anti-mouse Qa1b mAb
(6A8.6F10.1A6) and rat anti-mouse CD94 (18d3) were purchased
from BD Pharmingen. Mouse anti-human APC-conjugated granzyme
B (MHGB05) was purchased from Caltag Laboratories (Burlinghame,
CA). APC-conjugated anti-CD127 (A7R34) was purchased from eBio-
sciences (San Diego, CA). Rat anti-mouse perforin (clone P1-8) was
purchased from Kamiya Biomedical (Seattle, WA). Isotype control
antibodies were purchased from BD Pharmingen, Caltag, and Jack-
son ImmunoResearch (West Grove, PA).
Flow Cytometry of TG, Lungs, and Spleens
Mice were perfused with cold PBS, and TG, lungs, and spleens were
harvested for flow cytometric analysis. Lungs were digested in 500
ml of DMEM containing 400 U/ml of collagenase type I. Prior to stain-
ing, lung and spleen suspensions were treated with red blood cell ly-
sis buffer. Surface staining and flow cytometric analysis of TG,
lungs, and spleens pooled from several animals or from individual
animals was performed as previously described (Khanna et al.,
2003). Peptide-dimer complexes were used according to manufac-
turer’s instructions. Intracellular granzyme B and perforin staining
were performed directly ex vivo using Cytofix/Cytoperm (BD Bio-
sciences) after staining for cell-surface markers. Perforin staining
was performed as previously described (Slifka et al., 1999), and
the gB498-505-specific CD8
+ T cell line described above was used
for control staining.
Analysis of IFN-g, TNF-a, IL-2 Production, and Lytic
Granule Exocytosis by Optimally Stimulated CD8+
T Cells Directly Ex Vivo
The CD8+ T cells present in TG at 14 or 34 dpi were stimulated by
adding 5 3 105 stimulator cells to TG cell suspensions in the pres-
ence of FITC-conjugated anti-CD107a mAb (0.5 mg/ml) and Golgi-
plug (BD Biosciences) for 6 hr at 37ºC in flow tubes. The following
stimulatory cells were used: B6WT3 fibroblast cell line infected
with HSV-1 at an moi of 5 for 6 hr, or the gB-transfected cell line
B6/T-350gB that was also pulsed for 30 min with gB peptide
(10212 M) (Bonneau et al., 1993). Preliminary studies demonstrated
that these conditions provided optimal stimulation of IFN-g produc-
tion and LG exocytosis in a 6 hr assay (data not shown). Epitope den-
sity studies were conducted by pulsing B6WT3 cells with various
concentrations of gB peptide for 30 min. After the 6 hr stimulation,
the cells were stained for surface expression of CD8, followed by in-
tracellular staining for IFN-g, TNF-a, and IL-2 via Cytofix/Cytoperm
(BD Biosciences) and analyzed by flow cytometric analysis using
a FACSAria cytometer and FACSDiva software (BD Pharmingen).
CD107a (expressed on secretory vesicles) is transiently expressed
on the surface of CD8+ T cells that have exocytosed LG and is bound
by the FITC-conjugated anti-CD107a during the 6 hr stimulation,
providing sensitive detection of LG exocytosis (see Figure S4; Wolint
et al., 2004; Betts et al., 2004).
Analysis of IFN-g Production and LG Exocytosis by CD8+
T Cells in Response to Latently Infected TG Neurons
To assess IFN-g production and LG exocytosis by TG CD8+ T cells in
response to latently infected neurons, TG were excised 14 days after
infection with HSV-1 ICP0p-EGFP. The TG cells were pooled from
several mice, distributed into the wells of 96-well plates (1/10 TG/
well), and cultured for varying periods. IFN-g production and LG
exocytosis were measured during the periods of 0–6 hr, 24–30 hr,
48–54 hr, and 72–78 hr after culture initiation as described above, ex-
cept that no stimulator cells were added. The use of TG latently in-
fected with the RE-pICP0-EGFP provided a quick and sensitive
method of insuring that neurons are the only source of virus in the
cultures. Cultures were examined by fluorescence microscopy just
prior to removing cells for flow analysis. Within this 78 hr observation
period, some wells had EGFP-positive neurons, but no spread to
surrounding support cells was observed as previously noted
(Decman et al., 2005). This is consistent with our observation that
the endogenous CD8+ T cells in TG at 14 dpi can repress HSV-1 re-
activation from latency and virion formation (Liu et al., 2000). We find
that RE-pICP0-EGFP provides a very sensitive method of detecting
virion release from neurons during a reactivation event and have
confirmed these finding by standard plaque assay. The use of wt
HSV-1 RE did not influence the results.
rIn Situ Detection of HSV-1 gB Promoter Activity in Neurons
34 days after corneal infection with HSV-1, RE-pgB-EGFP mice were
perfused with PBS, and then TG were excised and processed for
whole-organ staining. Excised TG were washed in PBS and incu-
bated overnight at 4ºC in round bottom 96-well plates with purified
hamster anti-IFNgRa mAb (Clone CD119) (BD Pharmingen) and
mouse anti-Qa1b mAb (Clone 6A8.6F10.1A6) diluted in 2% normal
goat serum and PBS. Tissues were washed and incubated overnight
at 4ºC with Alexa Fluor 546 goat anti-hamster IgG (2 mg/ml, Molecu-
lar Probes) and Alexa Fluor 647 goat anti-mouse IgG (2 mg/ml, Mo-
lecular Probes) diluted in 2% normal goat serum and PBS. The tis-
sues were then washed, fixed with 2% paraformaldehyde for 30
min at 4ºC, and mounted on slides using Immu-Mount (Thermo
Shandon, Pittsburgh, PA). The stained whole-mount tissues were
analyzed with a Olympus IX70 inverted microscope (Olympus Amer-
ica, Melville, NY). Z-stack confocal images were captured and re-
corded in LaserSharp software via a Radiance liquid light acquisition
system (Bio-Rad Laboratories, Richmond, VA) and analyzed by
MetaMorph imaging software (Molecular Devices, Sunnyvale, CA).
Statistical Analysis
Statistical analyses were performed using a two-tailed unpaired t
test with 95% confidence intervals or Kaplan-Meier survival curve
analysis. All analyses were performed using GraphPad Prism 4 soft-
ware.
Supplemental Data
Supplemental Data include four figures and can be found with this ar-
ticle online at http://www.immunity.com/cgi/content/full/23/5/515/
DC1/.
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